Oncoinvent ASA

As of June 30, 2025, Oncoinvent ASA has 609,941.00 shares outstanding.

As of June 30, 2025, Oncoinvent ASA maintains a current ratio of 4.39, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2025.

As of the close on October 23, 2026, Oncoinvent ASA's stock has declined approximately 92.46% over the past 52 weeks. The 50-day moving average sits at 8.38, while the 200-day moving average is 8.44.

As of June 30, 2025, Oncoinvent ASA holds 5.55M in cash and equivalents against - - in total debt, resulting in a net debt position of -5.55M. Total book value stands at 5.65M, with working capital of 5.64M providing operational flexibility.

Oncoinvent ASA's most recent stock split took place on January 22, 2026 with a 100:1 split ratio.